What does Crane Company do?
Crane Company is a New York Stock Exchange-listed industrial technology manufacturer trading under ticker CR. It supplies mission-critical products where failure is costly: aircraft braking, power and sensing systems; microwave electronics; valves, pumps, instrumentation, cryogenic piping, and process controls. Today’s company is narrower and more technology-focused than the historic Crane conglomerate.
Two platforms define the operating portfolio
The official business-segment overview emphasizes engineered solutions rather than commodity volume. That distinction matters: Crane typically competes on certification, reliability, technical support, intellectual property, application knowledge, and installed-platform content. A student analyzing the company should therefore think of it as a portfolio of specialized industrial franchises, not as a general machinery producer.
How does Crane Company make money?
Crane earns revenue by selling engineered components, replacement parts, and systems to original-equipment manufacturers, distributors, municipalities, industrial operators, and government-related customers. Aerospace combines long-cycle platform content with aftermarket demand. Process Flow depends on plant investment, maintenance, infrastructure spending, and regulation. Both platforms seek attractive economics through technical qualification and operational reliability.
Where does pricing power come from?
Pricing power is strongest when the component is a small portion of the customer’s total system cost but has a large effect on safety, uptime, certification, or performance. Changing an approved aircraft component or a severe-service valve can require testing, engineering work, customer approval, and operational risk. Crane’s aerospace platform describes technologies spanning power, sensing, landing, and microwave applications; the process platform emphasizes high-reliability fluid handling and instrumentation. In both cases, technical qualification can matter more than the purchase price alone.
Which segments and products matter most?
Aerospace combines OEM exposure with recurring aftermarket demand
FY2025 Aerospace & Advanced Technologies sales included $397.3 million of commercial original equipment, $297.5 million of military original equipment, $247.5 million of commercial aftermarket products, and $106.6 million of military aftermarket products. This mix balances new-platform production with maintenance demand from the installed base.
Process Flow is concentrated in valves and related products
Process Valves and Related Products generated $947.6 million in FY2025, or roughly three quarters of Process Flow segment revenue. Commercial Valves contributed $147.4 million and Pumps and Systems contributed $161.1 million. The January 2026 addition of Panametrics, Reuter-Stokes, and optek-Danulat materially expands sensing and instrumentation, so future product mix should be more technology-rich than the FY2025 baseline shown in the 2025 Form 10-K.
| FY2025 product line | Sales | Share of company sales | Analytical role |
|---|---|---|---|
| Process Valves and Related Products | $947.6M | 41.1% | Largest family; chemical, pharma, cryogenic, nuclear, and industrial exposure. |
| Commercial aerospace OEM | $397.3M | 17.2% | Tied to aircraft build rates and content per platform. |
| Military aerospace OEM | $297.5M | 12.9% | Defense-program exposure with long qualification cycles. |
| Commercial aerospace aftermarket | $247.5M | 10.7% | Installed-base demand distinct from OEM production. |
| Pumps and Systems | $161.1M | 7.0% | Water and wastewater infrastructure exposure. |
| Commercial Valves | $147.4M | 6.4% | Construction, gas utility, and municipal demand. |
| Military aerospace aftermarket | $106.6M | 4.6% | Maintenance demand tied to defense fleets and platform utilization. |
What do Crane Company’s latest results show?
The newest official package covers the quarter ended March 31, 2026, the first period including Druck, Panametrics, Reuter-Stokes, and optek-Danulat. Results showed strong acquired growth and aerospace core demand, offset by acquisition amortization, transaction costs, higher interest expense, and seasonal working-capital outflows.
Growth quality was mixed but strategically informative
Q1 2026 sales growth consisted of 3.8% core growth, 18.3% acquisition contribution, and 2.7% favorable foreign exchange. Aerospace & Advanced Technologies reported $318.3 million of sales, up 27.9%, including 9.4% core growth. Process Flow Technologies reported $378.1 million, up 22.5%, but its core sales declined 0.6%; acquisitions added 19.2% and currency added 3.9%. Management’s Q1 2026 earnings release therefore points to a business where aerospace demand remained strong while Process Flow’s reported expansion was acquisition-led.
| Q1 2026 metric | Reported result | Q1 2025 comparator | Interpretation |
|---|---|---|---|
| Net sales | $696.4M | $557.6M | 24.9% growth, primarily acquisition-driven. |
| GAAP operating profit | $100.1M | $101.1M | Down 1.0% because acquisition costs and amortization offset volume and productivity. |
| Adjusted operating profit | $137.8M | $107.1M | Up 28.7%, showing positive underlying contribution from acquired businesses. |
| GAAP operating margin | 14.4% | 18.1% | 370-basis-point decline highlights accounting and integration effects. |
| Adjusted operating margin | 19.8% | 19.2% | 60-basis-point expansion indicates productivity and acquisition earnings exceeded dilution. |
| Net income from continuing operations | $67.1M | $78.3M | Higher interest expense and acquisition accounting pressured GAAP earnings. |
| Operating cash flow | -$29.5M | -$46.2M | Seasonal outflow improved year over year but remained negative. |
| Capital expenditures | $10.7M | $14.2M | Free cash flow was -$40.2M for Q1 2026. |
How financially strong is Crane Company?
Crane entered 2026 with stronger operations but higher leverage. FY2025 sales rose 8.2% to $2.305 billion, operating profit increased 19.2% to $424.2 million, and continuing net income reached $331.7 million. Operating cash flow of $394.8 million less $53.5 million of capex produced about $341.3 million of simple free cash flow, helped by improved working capital.
The acquisition reset leverage and asset mix
At December 31, 2025, Crane held $506.5 million of cash, $1.223 billion of restricted cash earmarked for the January acquisitions, and $1.148 billion of long-term debt. By March 31, 2026, after $1.355 billion of acquisition payments, cash was $355.4 million and total debt was $1.198 billion. Goodwill increased to $1.346 billion and intangible assets rose to $667.3 million at March 31, 2026. The Q1 2026 Form 10-Q makes the strategic trade-off clear: Crane exchanged liquidity and borrowing capacity for higher-growth sensing and instrumentation assets.
| Financial measure | FY2025 / year-end 2025 | Meaning |
|---|---|---|
| Net sales | $2.305B | 8.2% annual growth from continuing operations. |
| Operating profit | $424.2M | 18.4% operating margin; up from 16.7% in FY2024. |
| Net income from continuing operations | $331.7M | 14.4% net margin on continuing operations. |
| Operating cash flow | $394.8M | Strong conversion, including a $60.7M working-capital improvement versus FY2024. |
| Capital expenditures | $53.5M | Only 2.3% of sales, indicating moderate physical capital intensity. |
| R&D expense | $47.8M | About 2.1% of FY2025 sales, before the acquired technology businesses entered results. |
| Backlog | $1.076B | FY2025 aerospace backlog rose from $863.8M in FY2024. |
Which turning points still shape Crane today?
Crane’s long history matters where it explains current capabilities. The relevant sequence links fluid-control expertise, aerospace certification, portfolio separation, and acquisition discipline to today’s two-platform model.
-
1855Founded as a Chicago brass and bell foundry; early valves and steam systems established fluid-control expertise.
-
1942Technical Paper 410, the Flow of Fluids handbook, strengthened Crane’s authority in process engineering.
-
1947The first antiskid brake-control system began a long aerospace position built on safety-critical certification.
-
April 2023Crane Holdings separated into Crane Company and Crane NXT, sharpening focus and independent capital allocation.
-
2023-2024BAUM, Vian, CryoWorks, and Technifab added aerospace lubrication, chemical piping, and cryogenic capabilities.
-
January 2025The $227M Engineered Materials divestiture concentrated the portfolio on two growth platforms.
-
January 2026Druck, Panametrics, Reuter-Stokes, and optek-Danulat added sensing, nuclear, and biopharma technologies.
-
April 2026Alex Alcala became CEO and Max Mitchell Executive Chairman during the major integration phase.
Portfolio focus is the modern strategic story
The company’s official history and values page connects current culture to the founder’s 1855 commitment to honesty and fairness. For analysis, the more important point is how management uses that culture: a common operating system, internal talent development, technical-commercial excellence, and disciplined portfolio reshaping. The 2023 separation and subsequent transactions turned Crane from a diversified industrial collection into a more coherent set of mission-critical technology businesses.
What gives Crane Company a competitive advantage?
Crane does not disclose one company-wide market share because its niches are fragmented. Its moat is a portfolio of advantages: approved aircraft content, proprietary designs, application knowledge, installed-base aftermarket demand, recognized valve brands, engineering support, and reliable delivery in severe-service environments.
Qualification and reliability create switching friction
In aerospace, replacing an approved component can require redesign, testing, certification, and supply-chain requalification. In Process Flow, severe-service valves and sensors are selected around pressure, temperature, accuracy, safety, and maintenance. Switching is possible, but the engineering and operating burden can be substantial.
Who are the relevant competitors?
Competitors vary by niche. Aerospace overlap can include Parker Hannifin, Eaton, Honeywell, RTX businesses, Moog, and Curtiss-Wright. Flow and instrumentation peers can include Emerson, Flowserve, ITT, IMI, Spirax, and specialists. The analytical question is whether Crane protects differentiation and customer trust within each category.
Who owns Crane stock, and how is the company governed?
Crane uses one-share-one-vote governance. An unusual feature is The Crane Fund, a trust for former employees in need, disclosed with 7,778,416 shares, or 13.5%, in the 2026 proxy. Trustees are executive officers and the shares are voted as directed by the board, although directors and trustees disclaim direct beneficial ownership.
Institutional ownership increases governance scrutiny
The 2026 proxy statement lists Vanguard at 8.4%, BlackRock at 7.2%, and Capital World Investors at 5.2% based on the ownership sources described in the filing. Directors and executive officers as a group beneficially owned 2.12% as of January 31, 2026. This is a dispersed public-company structure in which passive institutions, the Crane Fund, and management incentives all matter.
| Holder or group | Disclosed stake | Source period | Why it matters |
|---|---|---|---|
| The Crane Fund | 7,778,416 shares; 13.5% | 2026 proxy ownership table | Board-directed voting creates a stable and distinctive governance influence. |
| The Vanguard Group | 4,832,731 shares; 8.4% | Schedule 13G basis cited in proxy | Large passive ownership increases attention to governance, compensation, and capital allocation. |
| BlackRock | 4,145,948 shares; 7.2% | Schedule 13G basis cited in proxy | Major index-oriented voting bloc. |
| Capital World Investors | 2,971,581 shares; 5.2% | Schedule 13G basis cited in proxy | Active ownership can emphasize earnings and capital deployment. |
| Directors and executive officers | 1,269,914 shares; 2.12% | January 31, 2026 | Management exposure and performance awards support alignment. |
Leadership continuity reduces succession risk but raises integration accountability
Alex Alcala became President and CEO effective April 27, 2026, and Max Mitchell became Executive Chairman. The official succession announcement presents the change as a planned transition. That continuity is useful while integrating $1.355 billion of acquired businesses, but it also means the new CEO will be judged quickly on synergy capture, organic growth, margin progression, cash conversion, and leverage reduction.
How does Crane allocate capital?
Post-separation capital allocation has emphasized acquisitions, portfolio focus, technology investment, dividends, and productivity spending. Crane made no common-share repurchases in FY2025. It instead borrowed $1.15 billion under a September 2025 credit agreement and combined debt with cash to fund the January 2026 acquisitions.
| Capital action | Amount / period | Strategic purpose | Research question |
|---|---|---|---|
| Druck, Panametrics, Reuter-Stokes acquisition | Approximately $1.06B announced net purchase price; closed January 1, 2026 | Adds advanced sensing across aerospace, nuclear, and process industries. | Can Crane deliver revenue synergies and restore leverage without sacrificing investment? |
| optek-Danulat acquisition | Closed January 1, 2026; business had about $40M of 2025 sales | Adds optical measurement in biopharma and pharmaceutical processes. | How quickly can the business scale through Panametrics channels? |
| FY2025 capital expenditures | $53.5M | Capacity, replacement equipment, product development, and systems. | Does capex remain near 2%-3% of sales as acquired businesses are integrated? |
| FY2025 R&D | $47.8M | New products and technology differentiation. | Will the enlarged sensing portfolio increase R&D intensity and vitality? |
| FY2025 dividends | $52.9M; $0.92 per share | Recurring shareholder distribution. | Can dividend growth continue while debt is reduced? |
| 2026 dividend rate | $0.255 quarterly; $1.02 annualized | 11% annual increase announced with FY2025 results. | Is free cash flow sufficient to cover dividends and deleveraging? |
What opportunities and risks could change the story?
Crane’s opportunities include commercial aerospace recovery, defense and space spending, aircraft electrification, nuclear instrumentation, pharmaceutical processing, cryogenic infrastructure, aging water systems, and tighter wastewater rules. Acquired sensing businesses also create cross-selling potential. After Q1, management raised 2026 adjusted EPS guidance to $6.65-$6.85, about 12% midpoint growth on its comparable basis.
The largest risks are execution, cycle exposure, and liability concentration
The 2025 filing highlights competition, product-development failure, supply costs, tariffs, cyber incidents, government-contract compliance, export controls, product liability, environmental remediation, and acquisition integration. The Goodyear site carried a $12.0 million gross liability at March 31, 2026. Because Crane products serve severe environments, a quality failure can create costs far beyond the original component revenue.
Which KPIs matter most for valuation?
A Crane valuation should separate organic growth, acquisition contribution, foreign exchange, margin quality, reinvestment, and leverage. A DCF should also distinguish temporary integration costs from the enlarged portfolio’s normalized earning power.
| KPI | Latest reference point | How to interpret it | DCF relevance |
|---|---|---|---|
| Core sales growth | 3.8% company-wide in Q1 2026 | Excludes acquisitions, divestitures, and FX. | Best starting point for organic revenue assumptions. |
| Core backlog growth | 9.1% in Q1 2026 | Indicates future demand, especially in aerospace and long-cycle products. | Supports near-term revenue visibility but is not identical to cash flow. |
| Adjusted operating margin | 19.8% in Q1 2026 | Shows operating performance before acquisition-related adjustments. | Useful for normalized margins, with a reconciliation to GAAP cash costs. |
| Segment margin | 24.6% Aerospace; 22.1% Process Flow in Q1 2026 | Tracks mix, pricing, productivity, and acquisition dilution. | Segment-level forecasts are more informative than one company margin. |
| Free cash flow conversion | $341.3M simple FCF in FY2025; -$40.2M in Q1 2026 | Seasonality and working capital create quarterly noise. | Use full-year conversion and normalize integration cash outflows. |
| Net debt | Approximately $842.8M at March 31, 2026 | Higher leverage raises interest expense and reduces optionality. | Affects equity value, discount risk, and capital allocation. |
| R&D and capex intensity | 2.1% and 2.3% of FY2025 sales | Measures reinvestment needed to defend technology and capacity. | Terminal margins should not assume underinvestment. |
What assumptions drive intrinsic value?
What is the key takeaway from Crane Company analysis?
Crane is a focused industrial technology company built around mission-critical components, engineering depth, qualification barriers, and operating discipline. FY2025 delivered $2.305 billion of sales, $424.2 million of operating profit, and about $341.3 million of simple free cash flow. The January 2026 acquisitions added valuable sensing franchises while increasing debt, goodwill, amortization, and integration complexity.
For students, Crane illustrates portfolio transformation and resource-based advantage through application knowledge, certified platform positions, installed-base relationships, specialist technologies, and a common operating system. The investor tension is whether legacy cash generation can fund integration, organic growth, and deleveraging.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.